Cutting-Edge Solutions

CGM BDO-Style EY Yellow Hero Animation
Cutting-edge solutions

Connecting healthcare providers with capabilities worthy of executive attention.

CGM represents select companies whose products, services, or operating capabilities can be highly valuable to healthcare providers. Each relationship is reviewed for provider relevance, differentiation, implementation readiness, organizational credibility, and the ability to address a defined healthcare operating priority.

View represented companies
Healthcare solution environmentHealthcare collaborationHealthcare technology discussionHealthcare advisory settingHealthcare provider environment
Market access

Access to specialized companies many healthcare providers may not otherwise evaluate.

Healthcare leaders are inundated with technologies, services, operating models, and competing claims. CGM helps providers focus on opportunities that warrant attention by identifying companies with credible offerings, differentiated capabilities, and clear provider applicability.

The emphasis remains on disciplined curation rather than vendor promotion. CGM evaluates whether a product or service addresses a real provider constraint, can support healthcare-market engagement, and is credible enough for leadership-level review before representation is established.

Most opportunities do not advance. Companies represented by CGM must demonstrate meaningful differentiation, provider relevance, and a practical path to measurable operating or clinical value.

Provider operating environment

Why specialized healthcare capabilities now require sharper evaluation.

Provider organizations are being asked to improve clinical throughput, reduce administrative drag, strengthen patient access, evaluate emerging assessment tools, and preserve margin while legacy systems, staffing limits, and reimbursement pressure remain persistent constraints.

CGM evaluates companies against these conditions before introducing them through its healthcare distribution network: whether they solve a defined provider issue, fit healthcare operating realities, demonstrate credible differentiation, and warrant leadership attention before deeper clinical, operational, legal, or financial review.

01

Administrative burden

Manual intake, prior authorization, documentation, AR follow-up, and fragmented handoffs continue to consume capacity that providers need for care delivery.

02

Clinical variation

Diagnostics, medication decisions, wound care protocols, and care-gap review require sharper tools when volume increases and teams operate across multiple sites.

03

Clinical and administrative complexity

Diagnostics, cognitive screening, medical-record review, patient logistics, pharmacy economics, revenue cycle execution, and practice continuity all require sharper evaluation as providers prioritize capacity, access, and outcomes.

04

Margin discipline

Pharmacy economics, revenue cycle execution, succession planning, and operating infrastructure increasingly determine how provider organizations fund modernization.

Service themes

Where represented companies map to provider operating priorities.

The represented portfolio is organized around provider priorities rather than company type: clinical execution, diagnostic access, cognitive health screening, technology resilience, revenue protection, pharmacy economics, data access, patient logistics, administrative capacity, and operational performance.
01

Care delivery execution

Tools and services for clinical decision-making, wound care coverage, medication-response insight, record consolidation, and care-gap review.

02

Healthcare workflow enablement

Resources for point-of-care diagnostics, cognitive health assessment, care-gap review, pharmacogenomics, pharmacy support, receivables execution, patient logistics, and provider financial planning.

03

Financial and administrative performance

Services tied to pharmacy operations, 340B consulting, revenue cycle execution, accounts receivable management, advisory resources, and business development coordination.

04

Healthcare operations and patient logistics

Capabilities for patient transportation, discharge coordination, ADA-compliant mobility, scheduling, dispatch, tracking, reporting, and care-continuity support.

Areas of active evaluation

Provider operating areas where emerging capabilities warrant closer review.

CGM reviews external capabilities against provider-system conditions rather than broad market claims. The emphasis is on operating fit, implementation readiness, governance implications, patient access, distribution readiness, and the likelihood that a product or service can address a defined healthcare constraint.

These areas reflect where provider leaders are increasingly evaluating outside capabilities and where CGM can introduce represented companies that have passed a selective review process and merit a more informed conversation.

01

Workflow orchestration

Coordinating fragmented clinical, administrative, and back-office processes across sites, teams, and systems.

02

Records and care-gap visibility

Turning fragmented medical records and documentation into concise summaries, care-gap plans, and provider-ready review paths.

03

Cognitive health screening

Reviewing scalable tools for early cognitive risk stratification, wellness screening, assessment workflow, and downstream clinical referral pathways.

04

Revenue-cycle modernization

Improving visibility into reimbursement coordination, AR execution, denial activity, and administrative yield.

05

Post-acquisition integration

Consolidating systems, workflows, vendor environments, and governance after provider expansion or affiliation.

06

Patient logistics coordination

Improving discharge transportation, mobility coordination, scheduling visibility, and non-emergency patient movement across care settings.

07

Clinical assessment workflow

Integrating digital screening, point-of-care diagnostics, pharmacogenomics, and care review into practical provider workflows.

08

Provider financial resilience

Reviewing pharmacy economics, receivables execution, succession planning, and practice-owner continuity as part of provider operating strength.

CGM Provider Evaluation Framework

A structured review process for capabilities seeking provider attention.

CGM serves as a selective bridge between healthcare providers and companies offering products or services that can address meaningful operating, clinical, financial, logistics, administrative, and technology challenges. Before a company is introduced through the network, CGM assesses whether the capability addresses a real provider constraint, whether the organization can support healthcare-market engagement, and whether the offering is credible enough for leadership-level review.

The CGM Provider Evaluation Framework considers management quality, market need, competitive differentiation, customer adoption, operational readiness, implementation complexity, compliance sensitivity, scalability, and alignment with provider economics. Companies that do not meet the threshold are not advanced as represented relationships.

CGM does not operate as an open vendor directory. Representation is selective, and access to the healthcare network is reserved for companies, products, and services that can withstand practical provider scrutiny.

01

Provider relevance

Determine whether the capability addresses a defined provider issue rather than a generalized market claim.

02

Market differentiation

Review category position, competitive alternatives, evidence of adoption, leadership credibility, and the reason a provider would take the meeting.

03

Implementation readiness

Assess workflow impact, compliance considerations, support capacity, commercial maturity, and scalability across healthcare settings.

04

Provider impact

Advance only qualified companies when the provider need, use case, and next-stage evaluation path are clearly defined.

Healthcare network snapshot

A selective model built around provider relevance, not vendor volume.

CGM uses average engagement benchmarks to evaluate whether represented companies are likely to merit provider attention. The objective is not to create a broad directory, but to identify products and services with clear use cases, credible leadership, and practical relevance across healthcare settings.

9 Represented companies

A curated portfolio spanning products, services, logistics, diagnostics, pharmacy, advisory, and administrative support.

4 Evaluation gates

Provider relevance, differentiation, implementation readiness, and measurable operating or clinical value.

8+ Provider priorities

Clinical workflow, diagnostics, cognitive screening, revenue cycle, pharmacy, patient logistics, records, and financial resilience.

1 Selective access point

A disciplined path for provider leaders to evaluate external capabilities without sorting through undifferentiated market noise.

Executive insights and evidence

Provider priorities supported by market evidence, not vendor claims.

CGM evaluates represented companies against healthcare issues that are visible in policy, clinical operations, reimbursement strategy, and provider workflow. These evidence points help frame why certain capabilities deserve executive review.

01

Clinical information access

CMS continues to promote secure exchange, access, and use of electronic health information so patients and providers can make better informed and more efficient decisions.

Source: CMS Interoperability

02

Antibiotic stewardship

CDC identifies improving antibiotic use as a core patient-safety strategy and provides outpatient stewardship guidance for clinicians and facilities that routinely prescribe antibiotics.

Source: CDC Outpatient Stewardship

03

PBM and pharmacy transparency

Recent PBM reform activity has focused on transparency, compensation structure, federal oversight, and visibility into prescription drug pricing and pharmacy reimbursement.

Source: AMA PBM Reform Brief

04

Cognitive health demand

National aging-data resources track indicators such as subjective cognitive decline, caregiving, screenings, mental health, and related public-health measures for older adults.

Source: CDC Healthy Aging Data

Provider challenges driving evaluation activity

Healthcare priorities creating demand for specialized capabilities.

Provider leaders are increasingly evaluating external capabilities that can improve access, reduce administrative burden, strengthen clinical decision-making, support stewardship initiatives, and improve operating performance. The represented portfolio aligns each product or service to a provider challenge that warrants executive review.

01

Clinical information fragmentation

Incomplete patient histories and disconnected records can create care gaps, duplicate work, and reduced visibility across care teams. Relevant capability: MedSync.

02

Antibiotic stewardship

Ambulatory and urgent-care providers need faster diagnostic insight when differentiating viral and bacterial signals during the encounter. Relevant capability: FebriDx.

03

Pharmacy economics

340B performance, dispensing strategy, adherence, PBM structure, and pharmacy infrastructure remain strategic provider priorities. Relevant capability: Wellyfe.

04

Cognitive health screening

Provider organizations are evaluating scalable assessment pathways, earlier identification programs, and downstream referral workflows. Relevant capability: iFunction.

05

Revenue integrity

Denials, collections performance, and accounts receivable execution continue to affect provider cash flow and administrative capacity. Relevant capability: iQuantified Management Services.

06

Patient logistics

Transportation coordination, discharge support, ADA-compliant mobility, and real-time logistics visibility remain operational challenges. Relevant capability: Myle.

07

Advanced wound management

Providers continue evaluating biologic options that support wound and tissue coverage strategies across specialty settings. Relevant capability: Applied Biologics XWRAP.

08

Provider continuity

Practice succession, partner protection, key-person planning, and long-term financial resilience remain leadership priorities. Relevant capability: Sky Gem Solutions.

Represented companies

A curated portfolio of products and services reviewed for provider relevance.

Each represented organization is framed by the provider issue it addresses, the operating environment it enters, and the reason its product or service may warrant leadership review. The portfolio reflects CGM's selective model: companies are introduced through the distribution network only after they are reviewed for relevance, differentiation, readiness, and fit across healthcare operations, clinical care, diagnostics, cognitive health, patient logistics, technology, pharmacy, and financial performance.
01 Wound care

Applied Biologics XWRAP

Amniotic membrane allograft

Service overview: Offers an amniotic membrane-derived allograft for wound and tissue coverage applications.

Provider use case: Expands biologic wound and tissue coverage options for wound care centers, podiatry groups, surgical practices, outpatient departments, and specialty providers.

Executive review: Primary provider stakeholder: wound care leadership, podiatry, surgery, outpatient specialty programs. Typical review lens: clinical fit, coverage pathway, site readiness.

Website
02 Diagnostics

FebriDx

Point-of-care respiratory testing

Service overview: Rapid point-of-care testing designed to differentiate bacterial versus viral signals during the patient encounter.

Provider use case: Brings point-of-care respiratory assessment into urgent care, primary care, pediatric, and ambulatory clinics to inform treatment decisions and strengthen antibiotic stewardship.

Executive review: Primary provider stakeholder: urgent care, primary care, pediatrics, ambulatory operations. Typical review lens: diagnostic workflow, antibiotic stewardship, point-of-care adoption.

Website
03 Cognitive health

iFunction

AI-enabled cognitive health screening

Service overview: Provides an AI and cloud-based cognitive assessment platform designed for early detection, population-scale deployment, and front-end risk stratification.

Provider use case: Supports clinics, health systems, senior-care programs, wellness initiatives, and provider organizations evaluating scalable cognitive screening workflows for Alzheimer's-related risk and referral pathways.

Executive review: Primary provider stakeholder: senior-care programs, wellness leaders, primary care, population health. Typical review lens: screening workflow, referral pathway, scale readiness.

Website
04 Care gaps

MedSync

Records and care coordination

Service overview: Converts fragmented medical records into concise summaries and provider-reviewed care-gap plans.

Provider use case: Converts fragmented records into actionable summaries for ACOs, primary care groups, CINs, and value-based care teams pursuing documentation accuracy and care-gap closure.

Executive review: Primary provider stakeholder: ACOs, CINs, primary care groups, value-based care teams. Typical review lens: records visibility, care-gap closure, documentation efficiency.

Website
05 Precision medicine

Resolve MDx

Pharmacogenomics testing

Service overview: Delivers pharmacogenomics testing and reporting for medication-response insight.

Provider use case: Brings medication-response intelligence into behavioral health, cardiology, pain, oncology-support, chronic disease, and polypharmacy programs where prescribing decisions require greater specificity.

Executive review: Primary provider stakeholder: behavioral health, cardiology, pain management, oncology support, chronic-care programs. Typical review lens: prescribing insight, workflow fit, clinical adoption.

Website
06 Financial planning

Sky Gem Solutions

Financial and insurance advisory

Service overview: Structures financial advisory, insurance planning, and wealth management resources.

Provider use case: Structures succession, key-person risk, partner continuity, benefits planning, and long-term financial resilience for physician owners, practice leaders, and provider executives.

Executive review: Primary provider stakeholder: physician owners, practice leaders, executives, partner groups. Typical review lens: continuity planning, risk protection, long-term financial resilience.

Website
07 Pharmacy

Wellyfe

National pharmacy services

Service overview: Covers pharmacy management, direct pharmacy care, pharmacy consulting, management services, and 340B advisory work.

Provider use case: Evaluates entity-owned pharmacy models, 340B operations, local dispensing access, adherence programs, and pharmacy-management infrastructure for FQHCs, hospitals, clinics, and provider groups.

Executive review: Primary provider stakeholder: FQHCs, hospitals, clinics, provider groups, pharmacy leaders. Typical review lens: pharmacy economics, 340B operations, adherence infrastructure.

Website
08 Revenue cycle

iQuantified Management Services

Healthcare receivables execution

Service overview: Executes healthcare-focused revenue cycle and accounts receivable management work.

Provider use case: Reduces AR follow-up backlog, denial friction, collections variability, and revenue cycle execution pressure across hospitals, physician groups, ambulatory providers, and specialty practices.

Executive review: Primary provider stakeholder: CFOs, revenue cycle leaders, ambulatory executives, specialty practices. Typical review lens: AR execution, denial friction, collections performance.

Website
09 Patient logistics

Myle

Healthcare operations and patient logistics

Service overview: Provides a healthcare-first transportation and patient logistics platform for scheduling, dispatch, real-time tracking, reporting, and managed mobility coordination.

Provider use case: Supports hospitals, surgical centers, health systems, nursing facilities, and care providers with door-to-door, room-to-room, ADA-compliant, post-discharge, and specialty patient transportation services.

Executive review: Primary provider stakeholder: hospitals, surgical centers, nursing facilities, discharge teams, care coordinators. Typical review lens: patient logistics, mobility coordination, reporting, continuity of care.

Website
Why companies partner with CGM

Healthcare-market access for companies with products and services providers should evaluate.

Many capable companies struggle to reach the right provider audience, translate their offering into an executive healthcare use case, or distinguish their value from broader market noise. CGM helps represented companies clarify provider relevance, position the use case, and pursue focused introductions through a selective healthcare network.

The relationship is most valuable when a company has a credible product or service, a clear provider problem to solve, and the operational maturity to support a real healthcare-market conversation.

01

Position the use case

Translate the offering into the provider issue, stakeholder, care setting, and operating priority it supports.

02

Assess readiness

Review whether the company can support healthcare-market engagement, implementation discussion, and follow-through.

03

Introduce selectively

Coordinate targeted conversations when the provider need and company capability are aligned.

04

Support next steps

Help keep the discussion anchored to provider priorities, evaluation criteria, and practical decision pathways.

How CGM creates healthcare-market access

A disciplined bridge between healthcare providers and selectively reviewed capabilities.

Healthcare organizations face pressure across diagnostics, cognitive health screening, clinical assessment, pharmacy infrastructure, workflow execution, automation, revenue cycle management, patient logistics, discharge coordination, and patient engagement. CGM introduces represented companies through its healthcare distribution network when the provider issue is clear, the product or service has advanced through selective review, and the capability deserves closer evaluation.

The review lens remains provider-focused: operating fit, implementation considerations, clinical applicability, patient access impact, organizational maturity, and long-term sustainability.

Vetting discipline

A due diligence lens before healthcare-market introduction.

Potential relationships are assessed for provider applicability, leadership credibility, operational maturity, implementation readiness, market differentiation, category strength, and distribution fit before representation.

The approach prioritizes operational credibility, implementation realism, provider-specific use cases, and responsible network access over broad positioning, category hype, or vendor claims.

Evaluation discipline

A disciplined path from market signal to provider-level conversation.

Most opportunities do not advance through the CGM review process. CGM evaluates leadership, differentiation, adoption, scalability, readiness, provider relevance, and expected impact before introducing a company to the network.

01

Define the issue

Clarify the provider priority before any company is introduced.

02

Validate fit

Assess whether the company fits the provider’s operating context.

03

Guide review

Review the use case, readiness, constraints, and potential impact.

04

Advance discussion

Coordinate next steps while keeping provider priorities central.

Next conversation

Evaluate selectively reviewed products and services against your healthcare priorities.

CG Moneta Consulting helps healthcare organizations separate credible opportunities from market noise. CGM identifies represented companies that may merit review, aligns their products or services to provider priorities, and coordinates focused evaluation across healthcare operations, patient logistics, cognitive health, clinical, financial, and technology initiatives.

Discuss provider priorities Review represented companies

Start with the provider issue. CGM can determine which represented company, product, or service deserves a focused discussion and whether the use case is strong enough to advance.